Celltrion is a leading global biopharmaceutical company that researches, develops and manufactures antibody biosimilars, new biologics and small molecule drugs. We have presented a new paradigm to the global biologics market with the launch of the world’s first antibody biosimilar. With our continuous effort to expand our biologics and small molecule drug portfolio, we help patients to return to their everyday lives in full wellness.